Clinical Trial Update: Exploratory Evaluation of [11C]MPC6827 [EARLY_Phase 1]

View source ↗

Summary

An exploratory early Phase 1 study of the PET tracer [11C]MPC6827 conducted by Columbia University, reporting initial safety/imaging findings in Alzheimer’s dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Amyotrophic Lateral Sclerosis

Drugs mentioned

• [11C]MPC6827 (MPC6827)

Snippet

Sponsor: Columbia University | Conditions: Neurodegenerative Diseases, Alzheimer Disease | EARLY_Phase 1 | Status: COMPLETED